Inclusion Criteria : 
  -  The patient completed Study 17972 A. 
  -  The patient and the patient's caregiver or identified responsible person is able to read and understand the Informed Consent Form. 
  -  The patient has signed the Informed Consent Form specific for Study 17972 B. 
  -  The patient can potentially benefit from 24 weeks of treatment with Lu AF11167 according to the investigator's clinical judgment. 
Exclusion Criteria : 
  -  The patient has any current primary psychiatric disorder other than schizophrenia diagnosed during study 17972 A
  -  The patient , in the opinion of the investigator , is at significant risk of suicide
Other in - and exclusion criteria may apply